TCM Biotech Competitors and Similar CompaniesClear all
TCM Biotech's competitors and similar companies include Lutonix, Intra-Cellular Therapies, Histocell and Centurion.
 TCM Biotech TCM Biotech (泰宗生物科技股份有限公司, also known as Taizong Biotechnology) is a biotech company that specializes in the research and development of drugs. |  Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. |  Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. |  Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine. |  Centurion Centurion is a biopharmaceutical company that focuses on manufacturing and launching biosimilar products. | |
Founding Date | Founding Date 1998 | Founding Date 2007 | Founding Date 2002 | Founding Date 2011 | Founding Date 1999 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Maple Grove, US HQ | Locations New York, US HQ | Locations Derio, ES HQ Larrabetzu, ES | Locations TR HQ |
Employees | Employees N/A | Employees 10 | Employees 330352% increase | Employees 365% decrease | Employees 1811% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$666.5m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $680.9m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income NT$21m (FY, 2024) | Net income N/A | Net income ($74.7m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 35m | Total funding raised $ 225.3m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Lutonix
HQ
Maple Grove, US
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.
View companyIntra-Cellular Therapies
HQ
New York, US
Employees
330
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
View companyHistocell
HQ
Derio, ES
Employees
36↓ 5% decrease
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
View companyCenturion
HQ
TR
Employees
181↓ 1% decrease
Centurion is a biopharmaceutical company that focuses on manufacturing and launching biosimilar products.
View company